Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Rona M Smith"'
Autor:
Simon Bond, Rachel B Jones, Rona M Smith, Kim Mynard, David R Jayne, Matthew Coates, Dominic Paul McGovern, Mark E McClure, Marcos Martinez Del Pero, Jacinta Lee, Menna Ruth Clatworthy
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction Relapses in ANCA-associated vasculitis (AAV) increase the incidence of end-organ damage and their prevention requires prolonged immunosuppressive therapy. Rituximab, a type I anti-CD20 B cell depleting monoclonal antibody, is the current
Externí odkaz:
https://doaj.org/article/439a1bae31204d01b880ed3f725a3132
Autor:
Rona M. Smith, Daniel J. Cooper, Rainer Doffinger, Hannah Stacey, Abdulrahman Al-Mohammad, Ian Goodfellow, Stephen Baker, Sara Lear, Myra Hosmilo, Nicholas Pritchard, Nicholas Torpey, David Jayne, Vivien Yiu, Anil Chalisey, Jacinta Lee, Enric Vilnar, Chee Kay Cheung, Rachel B. Jones
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Dialysis patients and immunosuppressed renal patients are at increased risk of COVID-19 and were excluded from vaccine trials. We conducted a prospective multicentre study to assess SARS-CoV-2 vaccine antibody responses in dialysi
Externí odkaz:
https://doaj.org/article/2e4719c10fc442a7b7d5dca898622e09
Autor:
Joanna Tieu, Rona M. Smith, Seerapani Gopaluni, Dinakantha S. Kumararatne, Mark McClure, Ania Manson, Sally Houghton, David R. W. Jayne
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveTo evaluate the characteristics of patients with autoimmune disease with hypogammaglobulinemia following rituximab (RTX) and describe their long-term outcomes, including those who commenced immunoglobulin replacement therapy.MethodsPatients
Externí odkaz:
https://doaj.org/article/bd3ce9c9a88440ebad989131ab748a89
Autor:
Balazs Odler, Regina Riedl, Philipp Gauckler, Jae Il Shin, Johannes Leierer, Peter A Merkel, William St. Clair, Fernando Fervenza, Duvuru Geetha, Paul Monach, David Jayne, Rona M Smith, Alexander Rosenkranz, Ulrich Specks, John H Stone, Andreas Kronbichler
Publikováno v:
Annals of the Rheumatic Diseases. 82:681-687
ObjectivesSevere infections contribute to morbidity and mortality in antineutrophil cytoplasm antibody-associated vasculitis (AAV). This study aimed to identify risk factors associated with severe infections in participants of the Rituximab versus Cy
Autor:
Dominic McGovern, Rachel B Jones, Lisa C Willcocks, Rona M Smith, David R W Jayne, Andreas Kronbichler
Publikováno v:
Nephrology Dialysis Transplantation. 38:1067-1070
Autor:
Allyson C. Egan, Andreas Kronbichler, Irmgard Neumann, Alessandra Bettiol, Nicholas Carlson, Maria C. Cid, Giacomo Emmi, Seerapani Gopaluni, Lorraine Harper, Thomas Hauser, Mark A. Little, Raashid A. Luqmani, Alfred Mahr, Mark McClure, Aladdin J. Mohammad, Karl Emil Nelveg-Kristensen, Sophie Ohlsson, Chen Au Peh, Matthew Rutherford, Beatriz Sanchez Alamo, Jennifer Scott, Mårten Segelmark, Rona M. Smith, Wladimir M. Szpirt, Gunnar Tomasson, Giorgio Trivioli, Augusto Vaglio, Michael Walsh, Maria Wester Trejo, Kerstin Westman, Ingeborg M. Bajema, David R.W. Jayne
Publikováno v:
Kidney International Reports. 7:1745-1757
The first European Vasculitis Society (EUVAS) meeting report was published in 2017. Herein, we report on developments in the past 5 years which were greatly influenced by the pandemic. The adaptability to engage virtually, at this critical time in so
Autor:
Edward J Carr, Mary Wu, Ruth Harvey, Roseanne E Billany, Emma C Wall, Gavin Kelly, Michael Howell, George Kassiotis, Charles Swanton, Sonia Gandhi, David LV Bauer, Matthew PM Graham-Brown, Rachel B Jones, Rona M Smith, Stephen McAdoo, Michelle Willicombe, Rupert Beale
Publikováno v:
The Lancet. 399:800-802
Autor:
Jennifer Scott, Stephen P. McAdoo, Mark A. Little, David Jayne, Matthew A Rutherford, Rona M Smith, Maira Karabayas, D. Gray, Seerapani Gopaluni, Marilina Antonelou, Neeraj Dhaun, Neil Basu, Silke R. Brix, Colin C. Geddes, Alan D. Salama, Raashid Luqmani, Joe Barrett
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective COVID-19 is a novel infectious disease with a broad spectrum of clinical severity. Patients with systemic vasculitis have an increased risk of serious infections and may be at risk of severe outcomes following COVID-19. We undertook this st
Publikováno v:
Rheumatology. 60:iii1-iii5
Autor:
Rona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Alastair Ferraro, Lindsy Forbess, Shouichi Fujimoto, Shunsuke Furuta, Ora Gewurz-Singer, Lorraine Harper, Toshiko Ito-Ihara, Nader Khalidi, Rainer Klocke, Curry Koening, Yoshinori Komagata, Carol Langford, Peter Lanyon, Raashid Luqmani, Carol McAlear, Larry W Moreland, Kim Mynard, Patrick Nachman, Christian Pagnoux, Chen Au Peh, Charles Pusey, Dwarakanathan Ranganathan, Rennie L Rhee, Robert Spiera, Antoine G Sreih, Vladamir Tesar, Giles Walters, Caroline Wroe, David Jayne, Peter A Merkel
Publikováno v:
Annals of the Rheumatic Diseases. :ard-2022
ObjectiveFollowing induction of remission with rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) relapse rates are high, especially in patients with history of relapse. Relapses are associated with increased exposure to im